Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine misoprostol plus intravenous oxytocin for reducing blood loss during cesarean delivery
TCTR20261015009Phase 4Not yet recruiting
- Sponsor
- Prapokklao Hospital
- Start
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of misoprostol, oxytocin in postpartum hemorrhage (PPH), sponsored by Prapokklao Hospital. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
misoprostoloxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on TCTR20261015009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261015009.